newsfilter
← Latest News
GlobeNewswire·

Axsome Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it